Research Paper Volume 15, Issue 5 pp 1524—1542
High expression of TARS is associated with poor prognosis of endometrial cancer
Figure 9. Predictive value of TARS expression in disease specific survival. (A, B) ROC curves evaluating the TARS expression for predicting disease specific survival. (C) Nomogram predicted 1-year disease specific survival vs. actual 1-year disease specific survival. (D) Nomogram predicted 3-year disease specific survival vs. actual 3-year disease specific survival. (E) Nomogram predicted 5-year disease specific survival vs. actual 5-year disease specific survival. (F–H) Decision curve analysis reflects the feasibility of TARS expression in predicting 1-year, 3-year, and 5-year disease specific survival.